Cross-sectional data often fail to show beneficial effects of antihypertensive therapy in patients with hypertension. We, therefore, examined the influence of hypertension control on left ventricular (LV) structure in diabetic persons separated into those having and not having any known cardiovascular disease (CVD) symptoms. The study population consisted of 394 subjects with type II diabetes. According to the presence of CVD, subjects were classified as symptomatic (N ¼ 181) or asymptomatic (N ¼ 213). In addition, three groups were differentiated: controlled hypertensives (CHs), that is, known hypertension with normal blood pressure (BP), uncontrolled hypertensives (UHs), that is, elevated BP regardless of antihypertensive medication, and normotensives (Ns). Symptomatic subjects showed a significantly higher prevalence of LV hypertrophy (LVH) (34.5 vs 23.4%, Po0.02). In contrast to symptomatic subjects where hypertension control status had no further significant impact on LV geometry, a considerable impact on preservation of normal LV geometry was observed in asymptomatic persons (LVH of 30, 15 and 18% in UH, CH and N, respectively, Po0.001). Control of hypertension in early diabetes seems especially to prevent the development of concentric hypertrophy (24 vs 11% in UH vs CH, Po0.04). In conclusion, in subjects with diabetes and CVD, the prevalence of LV structural abnormalities is very high. Although in this populationbased study setting, in the latter group BP control does not seem to positively influence LV mass and function, hypertension control in still asymptomatic diabetic persons is beneficial and has a considerable impact on preservation of normal LV geometry.
Introduction
The significantly increased cardiovascular disease (CVD) risk associated with type II diabetes 1,2 is mainly owing to left ventricular (LV) structural and functional abnormalities in addition to, and independent of, microvascular dysfunction of the coronaries. 3, 4 The coexistence of high blood pressure (BP) and diabetes has more detrimental effects on LV structure and function than one of these risk factors alone. [5] [6] [7] Especially, the concentric forms of LV hypertrophy (LVH), which are known to be associated with a worse prognosis, [8] [9] [10] are related to the occurrence of diabetes and hypertension. 5, 7, 11 Good BP control may be as important as, if not more important than, blood glucose control in the reduction of the CVD complications. 12, 13 Although clinical trials have shown that antihypertensive therapy in diabetic patients may be of prognostic relevance, [14] [15] [16] there exist no data on the effect of antihypertensive therapy and therapy control on LV structure and function in persons with type II diabetes at the population level. However, investigating the therapeutic effects of medication on specific surrogate parameters in population-based studies is often influenced by the problem of confounding by indication. 17, 18 That is, the more ill patients are better identified by the medical system, and, therefore, more often treated with the disease-specific and efficiency proofed medication. Therefore, there has been a controversy about the usefulness of observational data to study the efficacy of drugs. 19 Thus, in the present study, we examined LV structure and function in diabetic subjects divided into those already having CVD symptoms or complications, and asymptomatic patients with still no known CVD complication with regard to the presence of hypertension and hypertension control status.
Materials and methods
The present study was part of the Augsburg Diabetes Family Study, which was conducted from October 2001 to September 2002 with the primary goal to enrol nuclear families to investigate the role of genes as well as environmental factors in the development of type II diabetes. Families were ascertained through an index proband with known type II diabetes having at least one full sib or both parents willing to participate in the study. Index probands all came from the city or region of Augsburg. Altogether 1393 subjects were extensively phenotyped in the KORA study centre. The present investigation was organized as a substudy for which all participants being investigated were offered an additional echocardiographic examination. For logistical reasons, echocardiography was available only until April 2002, and 870 probands have been included in the study. Of those, a total of 800 individuals agreed to be examined by echocardiography (92%). Participants without echocardiographic examination did not significantly differ from those with echocardiography in terms of age, BP or body mass index (BMI). For the present study, only subjects with known or newly diagnosed diabetes were considered for further analysis (N ¼ 491). Anthropometric data were measured under standardized conditions as described previously. 20 BP was measured at the right arm in a sitting position after a 15-min rest using a validated automatic device (OMRON HEM 705-CP). BP was read three times and the mean of the second and third measurements was used for this study. Mean BP was calculated as 1/3 systolic þ 2/3 diastolic BP.
Fat-free mass (FFM) was determined by measuring bioelectrical impedance. 21, 22 Laboratory procedures Serum glucose was measured using a hexokinase method (Dade-Behring, Germany). Serum levels of creatinine were determined using a modified Jaffe test (KREA Flex, Dade-Behring, Germany). Lowdensity lipoprotein (LDL) cholesterol was measured by a direct homogeneous method (LDL-Plus, GreinerBiochemica, Germany) and HbA1c was determined with a turbidimetric immunological inhibition essay (TINIA; antigen-antibody reaction, Dade-Behring, Germany).
Echocardiographic measurements
Two-dimensional-guided M-mode echocardiograms were performed by two expert sonographers using the Sonos 3500 of Hewlett Packard Inc., USA. All M-mode tracings were recorded on video and on stripchart paper at 50 mm/s and were analysed by the senior observer (BK) who was blinded for all other data. Eighty-nine subjects (18%) with suboptimal echocardiographic readings or significant valvular heart disease were excluded. The latter had a slightly higher mean BMI (31.4 vs 30.3 g/m 2 ; Po0.05) and greater left atrial (LA) diameter (4.26 vs 4.03 cm, Po0.001) than those with adequate echocardiographic readings, however, with no significant differences in mean age and systolic or diastolic BP.
LV mass (LVM) was derived from the widely applied formula described by Devereux and associates. [23] [24] [25] The rank correlation for LVM in 30 duplicate measurements of the two sonographers was 0.89 and there was a mean difference (systematic bias) between both observers of 8.3 g with a standard deviation of 13 g.
According to reference values derived from the same population, LVH was defined as LVM44.1 g/ kg FFM for both genders or of 46 g/m 2.7 for men and 42 g/m 2.7 for women, when height raised by a power of 2.7 was chosen as indexation method. 22, 26 A partition value of 0.41 for relative wall thickness (RWT), the sum of septal and posterior wall thickness divided by two divided by end diastolic diameter, was used for the definition of patterns of LV geometry: normal geometry was considered when LVM/FFM was normal and RWTo0.41, LV remodelling was considered when normal LVM/FFM was combined with RWT40.41, concentric LVH was considered when LVH occurred with an RWT40.41 and eccentric LVH was considered when LVH was present together with an RWTo0.41.
27,28
The pulsed-Doppler examination of transmitral blood flow was performed from the apical fourchamber view according to standardized conditions with estimation of early filling peak velocity (E wave), the late filling peak velocity (A wave) and their ratio (E/A ratio). The time of E velocity deceleration was measured as the interval between the peak E velocity and the point at which the descending segment of the E-wave, or its asymptote, crosses the zero-velocity line. Mitral inflow measurements (E and A) were also obtained during phase II (straining) of the Valsalva manoeuver. The manoeuver was considered valid only if there was a 410% decrease in E velocity compared with baseline. 29 All recordings were performed at a paper speed of 50 or 100 mm/s, and three consecutive beats were analysed for each variable. Recordings with sufficient quality in transmitral Doppler were available for 391 (E-wave) and 371 (A-wave) subjects. Subjects with missing values were significantly older, however with no differences in LVM, RWT, systolic BP or BMI. Owing to the inability to follow the instruction for performing the Valsalva manoeuver or because of insufficient quality of recordings, only 323 subjects had sufficient recordings of the E/A ratio under Valsalva conditions. Subjects with insufficient Valsalva data were significantly older with no other significant differences compared to those with adequate recordings.
Groups of type II diabetic participants Self-reported type II diabetes was validated in most cases by hospital records or by contacting the physician who treated the participants. All subjects without known diabetes had an oral glucose tolerance test after an overnight fast. Type II diabetes was diagnosed according to the 1999 criteria of the WHO. 30 Subjects with type II diabetes were divided into symptomatic and asymptomatic persons with regard to the presence of CVD. Participants were classified as symptomatic when there was already manifestation of overt CVD. Therefore, symptomatic patients were characterized by fulfilling one of the following criteria: known myocardial infarction (MI), known coronary artery disease, former heart surgery, history of cerebrovascular disease, physician diagnosed congestive heart failure, complaints of angina pectoris (Rose questionnaire 31 ) or claudicatio intermittens. Two hundred and eighteen participants were classified to this group. We excluded patients on dialysis because the effects of uremia and modality of dialysis may have extraordinary impact on LV structure. Excluding another 30 persons with insufficient echocardiographic readings resulted in 181 patients belonging to the symptomatic group. The remaining diabetic subjects (N ¼ 273) were classified as asymptomatic. Asymptomatic means that there is still no known typical CVD complication. The background of that approach is that we tried to overcome the often-seen finding of confounding by indication when investigating the effects of antihypertensive therapy on LV structure in cross-sectional studies. Exclusion of those with insufficient echocardiographic readings and of one patient with insufficient BP recording resulted in 213 subjects in the asymptomatic group.
Within the symptomatic and asymptomatic groups, all persons were additionally divided according to hypertension status and treatment efficacy: subjects were classified as controlled hypertensive (CH) if they had known hypertension and BP values o140/90 mm Hg (all treated with antihypertensives); they were classified as uncontrolled (that means inadequately controlled) hypertensive (UH) if they had a BP X140/90 mm Hg regardless of antihypertensive medication (73% were on treatment with antihypertensives); and finally they were classified as normotensive (N) if they received no antihypertensive medication and their BP was o140/90 mm Hg. The background of using the more conservative cut point of 140/90 mm Hg instead of 130/80 mm Hg 32 in determining BP control is owing to the fact that this is a populationbased study showing the 'real world' situation where the optimal BP of o130/80 mm Hg is rarely achieved (only eight subjects in the symptomatic and 26 subjects in the asymptomatic group had optimal BP values with both systolic o130 mm Hg and diastolic BP o80 mm Hg).
Statistical analyses
Means and prevalences of baseline characteristics of the study subjects were calculated for symptomatic vs asymptomatic participants, and for the different groups according to their hypertension status. Statistical significance was assessed by a two-way analysis of variance for continuous variables and by w 2 tests for prevalences. Analysis of covariance was applied to calculate age, BMI and gender-adjusted mean values of LV parameters across the groups of subjects. As there were no statistically significant gender effects in the observed relationships between LV parameters and hypertension with respect to hypertension control status, results were presented for both genders combined. A variable originally incorporated in the multivariate models controlling for familiar interaction (family relation) showed no significant effect and, therefore, was excluded from the final models. Prevalence differences in geometric types of LVH between the respective subgroups were tested by logistic regression analysis controlling for age, BMI and gender. All analyses were carried out with the SAS System for Windows Release 6.11.
Results
Characteristics of the study population There were no significant differences between symptomatic and asymptomatic subjects regarding age, BMI, glucose, haemoglobin A 1c and BP (Table 1) . They also showed a similar duration of diabetes history, whereas the proportion of men was higher among symptomatic patients, and the proportion of antihypertensive therapy was significantly higher in symptomatic subjects. Accordingly, heart rate was lower in symptomatic persons as was LDL-cholesterol. LVM indexed or unindexed was higher with a significantly higher prevalence of LVH in symptomatic participants (33.5 vs 23.4%, based on FFMindexation, Po0.03).
Whereas especially the prevalence of concentric forms of LV geometry was remarkably high in all persons with type II diabetes with similar prevalences in symptomatic vs asymptomatic subjects (concentric remodelling 27 vs 28%, concentric hypertrophy 22 vs 18%, respectively, P for each comparison n.s.), the prevalence of eccentric LVH was significantly higher in symptomatic subjects (13 vs 6%, Po 0.03).
In addition, systolic LV function was diminished in symptomatic persons (fractional shortening 34 vs 39%, Po0.01), a significant difference that persisted after exclusion of those with a history of MI. LA size was greater in symptomatic subjects, whereas other parameters of diastolic function were inconsistently different between the two groups ( Table 1) .
From all symptomatic subjects, 30 were N and 61 were CH, that is, they had a history of hypertension, but normal measured BP. Fifty-one of the asymptomatic persons were N and 47 were CH. The proportion of UHs was high in both groups (49.7 and 54% in symptomatic and asymptomatic diabetic persons, respectively).
There were no differences in LVM, prevalencedifferences in LVH, differences in LA size or relevant differences in systolic or diastolic function in relation to hypertension and hypertension control status in symptomatic persons. The only relevant difference between hypertensives and Ns in this group was seen for RWT with higher RWT in the hypertensives (with no difference between CHs and UHs) ( Table 2) .
However, in asymptomatic persons, those with uncontrolled hypertension had remarkably higher LVM, and, accordingly, a much higher prevalence of LVH compared to those with controlled hypertension or normotension (30% in UHs vs 15% in CHs vs 18% in Ns, Po0.001). Especially, RWT was significantly higher in the uncontrolled group. No significant differences existed for systolic dysfunction and diastolic function except E/A ratio under Valsalva conditions (Table 2 ). Of interest, in symptomatic hypertensive patients, hypertension control status had no relevant impact on the geometric LV pattern. However, in the asymptomatic group, the prevalence of concentric hypertrophy was most prominent in the uncontrolled group (24 vs 11% in the controlled group, Po0.04), whereas concentric remodelling was mostly prevalent in the CHs (34 vs 29% in UH vs 22% in Ns, P ¼ n.s.) ( Figure 1 ).
Discussion
In this population-based study, we examined the impact of hypertension and BP control status on LV structure and function in persons with type II diabetes.
The major findings of this study are that diabetic subjects who already suffered from at least one major cardiovascular complication show a high prevalence of LVH and compromised LV systolic function. Furthermore, in this group of subjects, the hypertension and hypertension control status seem not to have a significant impact on LVM and function. On the other hand, in still asymptomatic subjects with type II diabetes, the control of hypertension has a considerable impact on preservation of normal LV geometry.
It has earlier been shown that diabetes mellitus is associated with higher LVM, more concentric LV geometry and lower cardiac function. 5, 7 These cardiovascular abnormalities are known to predict higher rates of cardiovascular events in both asymptomatic and symptomatic subjects and may contribute in part to the high rates of coronary heart disease and heart failure observed among diabetic patients. 33 Our data are in accordance with these earlier findings showing a high prevalence of LVH with a predominance of concentric LV structural abnormalities in diabetic subjects. 11 For example, whereas the overall prevalence of LVH in the same source population (city of Augsburg) using the same hypertrophy criteria was about 17%, 22 asymptomatic persons with uncontrolled hypertension or symptomatic persons regardless of their hypertension status showed LVH prevalences of 30% and above in the present study.
The proneness of developing concentric hypertrophy in type II diabetic subjects might be ex- Duration of diabetes was unknown in 10 patients (for those with newly diagnosed diabetes, diabetes duration was artificially set as 0.5 years).
Hypertension control and diabetes B Kuch et al plained by insulin resistance and the accompanying compensatory hyperinsulinaemia, which is regarded as the pathophysiological key feature underlying type II diabetes. Insulin has been regarded as a trophic factor responsible for the development of cardiovascular hypertrophy. 34 The direct and indirect stimulating effect of insulin on the sympathetic nervous system may contribute to the concentric change in the LV by increasing peripheral resistance. 35 Furthermore, in the present study, those already having cardiovascular complications showed higher LVM, and in addition to the overall high prevalence of concentric LV forms, an increasing frequency of eccentric LVH compared to still asymptomatic diabetic subjects. This was accompanied by an impaired systolic function in symptomatic diabetic persons, which even persisted after exclusion of those with a history of MI. Thus, these findings suggest either impaired LV structure and function as a consequence of already suffered cardiovascular complications, or a higher degree of accompanying risk factors in symptomatic diabetic persons leading to more detrimental effects on the heart. However, there were no differences in diabetes duration, BP or haemoglobin A 1c between symptomatic and asymptomatic persons. LDL-cholesterol and heart rate were even lower in the symptomatic, and a significant proportion was treated with antihypertensive medication. So far, despite the fact of seemingly adequate treatment in these persons (86% on antihypertensive medication), the high prevalence of LVH seems to be contradictory to the proposed efficient beneficial effect of antihypertensives on diabetic hearts. There are at least two possibilities, which both could be responsible for this observation. Firstly, the number and doses of antihypertensives together with other preventive medication are insufficient or, secondly, there is given confounding by indication. The first is supported by the frightening fact that the proportion of UHs was high in both groups (around 50%), although we did use the more conservative definition of hypertension. Unfortunately, this observation is not uncommon and in fact is detectable with Hypertension control and diabetes B Kuch et al similar proportions in many other European and non-European countries. 36, 37 The second means that the more ill patients are better identified by the medical system, and, therefore, more often treated with the disease-specific and efficiency proofed medication. 17, 18 We tried to overcome this confounding by indication by analysing separately the effects of hypertension and hypertension control status on LV structure and function in patients with diabetes with assumable still no cardiovascular complications. Of interest, in this group, those with uncontrolled hypertension had an LVH prevalence as high as the prevalence in symptomatic persons without hypertension (30 vs 33%; Table 2 ) and it was also remarkably higher in comparison to the group of asymptomatic subjects with controlled hypertension (15%, Po002). Participants with controlled hypertension in the asymptomatic group, however, revealed no significant differences compared to those with normal BP in terms of LVM and geometry, systolic and diastolic dysfunction, and the effect of hypertension and hypertension control seems to have no or minor influence on these parameters in already symptomatic persons. In addition, in the asymptomatic group, the prevalence of concentric hypertrophy was most prominent in the UHs, whereas concentric remodelling was mostly prevalent in the controlled (Figure 1 ) suggesting that control of hypertension in early diabetes may especially prevent the development of concentric hypertrophy, which is known to be associated with a worse prognosis. [8] [9] [10] On the other hand, for the symptomatic group, we cannot exclude that the socalled 'reverse causation' was responsible for the fact that no differences between the hypertension subgroups could be detected. If a patient had a previous MI, it could be expected that BP regulation is influenced, both by the scarring process of myocardial tissue and by the use of several drugs given for secondary prevention. Therefore, the finding of no difference in LV geometry and function between the hypertension subgroups of symptomatic patients could reflect that some individuals might have had a lowered BP ( ¼ controlled hypertension or normotension) owing to the MI effects on myocardial function per se.
There were no major differences regarding diastolic parameters except E/A ratio under Valsalva manoeuver, which by their lower ratios may have unmasked an underlying relaxation abnormality 29 in the hypertensive groups (significant only for the uncontrolled group) compared to Ns. This observation, however, has to be interpreted with caution because of the high number of persons with inability to follow Valsalva manoeuver or inadequate echocardiographic readings.
Study limitations
We did not make further invasive or non-invasive investigations like coronary angiography, treadmill test or indirect estimation of atherosclerosis signs such as measurement of carotic intimal-media thickness, to clearly characterize the asymtomatics as really free from CVD. However, our findings of the protective role of sufficient hypertension control would even be more pronounced by excluding some presumably 'false negative' healthy-classified patients. Furthermore, BP was measured by standardized methods during a single visit instead of using 24 h measurement, which may better correlate with hypertensive target organ damage. 38 However, in an earlier study investigating the effectiveness of adequate BP control in hypertensives, the effects with regard to LVH were similar, whether measured under office condition or were 24-h home measurements. 39 In addition, we were not able to apply the relatively new echocardiographic techniques of colour M-mode and tissue Doppler, which may provide more accurate estimates of diastolic or systolic function. 40, 41 In conclusion, in the present study, we confirm earlier studies that show a high prevalence of LV structural and functional abnormalities in persons with type II diabetes, especially when combined with hypertension. [5] [6] [7] The alarming high prevalence of insufficiently treated diabetic subjects with hypertension in this population-based study shows that translating the recommendations of clinical guidelines and the findings from research studies into daily clinical practice remains a daunting challenge. On the other hand, although it has been debated whether observational data to study the efficacy of drugs are sufficient, 19 our data indicate that at least in still asymptomatic diabetic persons the efficient control of hypertension is beneficial.
What is known about this topic K The coexistence of high BP and diabetes has more detrimental effects on LV structure and function than one of these risk factors alone. K Especially, the concentric forms of LVH, which are known to be associated with a worse prognosis, are related to the occurrence of diabetes and hypertension. K Clinical trials have shown that good BP control may be as important as, if not more important than, blood glucose control in the reduction of the CVD complications.
What this study adds K Diabetic subjects with already manifest cardiovascular disease show a remarkable high prevalence of LVH and compromised LV systolic function. K The alarming high prevalence of insufficiently treated diabetic subjects with hypertension in this population-based study suggests that a better translating of clinical guideline recommendations and findings from research studies into daily clinical practice is necessary. K Not only in clinical trials, but also at the population level it could now be shown that at least in still asymptomatic subjects with type II diabetes the control of hypertension may have a considerable impact on preservation of normal LV geometry.
Abbreviations: BP, blood pressure; CVD, cardiovascular disease; LV, left ventricular; LVH, left ventricular hypertrophy.
